Observational studyMedicine2026
Post-marketing safety analysis of nafamostat: A retrospective pharmacovigilance study using the Japanese Adverse Drug Event Report (JADER) database.
Yi Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.